 | • レポートコード：QYR2104Z4015 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん治療におけるナノテクノロジーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ナノ粒子、ナノロッド、ナノファイバー、グラフェン、金属有機構造体、ナノバイオセンサー、ナノ流体デバイス、ナノツール）、用途別市場規模（がん検出、画像、ドラッグデリバリー、放射線療法、免疫療法、光線療法）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん治療におけるナノテクノロジーの市場動向 ・企業の競争状況、市場シェア ・がん治療におけるナノテクノロジーの種類別市場規模（ナノ粒子、ナノロッド、ナノファイバー、グラフェン、金属有機構造体、ナノバイオセンサー、ナノ流体デバイス、ナノツール） ・がん治療におけるナノテクノロジーの用途別市場規模（がん検出、画像、ドラッグデリバリー、放射線療法、免疫療法、光線療法） ・がん治療におけるナノテクノロジーの北米市場規模2016-2027（アメリカ、カナダ） ・がん治療におけるナノテクノロジーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん治療におけるナノテクノロジーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん治療におけるナノテクノロジーの中南米市場規模2016-2027（メキシコ、ブラジル） ・がん治療におけるナノテクノロジーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Combimatrix Corporation、GE Healthcare、Sigma-Tau Pharmaceuticals Inc.、Johnson & Johnson、Mallinckrodt Plc、Merck & Company Inc.、Nanosphere Inc.、Pfizer, Inc.、Celgene Corporation） ・結論 |
Market Analysis and Insights: Global Nanotechnology in Cancer Treatment Market
The global Nanotechnology in Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanotechnology in Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanotechnology in Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanotechnology in Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanotechnology in Cancer Treatment market.
Global Nanotechnology in Cancer Treatment Scope and Market Size
Nanotechnology in Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanotechnology in Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nanoparticles
Nanorods
Nanofibers
Graphene
Metal-Organic Frameworks
Nanobiosensors
Nanofluidic Devices
Nanotools
Segment by Application
Cancer Detection
Imaging
Drug Delivery
Radiotherapy
Immunotherapy
Phototherapy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Combimatrix Corporation
GE Healthcare
Sigma-Tau Pharmaceuticals Inc.
Johnson & Johnson
Mallinckrodt Plc
Merck & Company Inc.
Nanosphere Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nanoparticles
1.2.3 Nanorods
1.2.4 Nanofibers
1.2.5 Graphene
1.2.6 Metal-Organic Frameworks
1.2.7 Nanobiosensors
1.2.8 Nanofluidic Devices
1.2.9 Nanotools
1.3 Market by Application
1.3.1 Global Nanotechnology in Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer Detection
1.3.3 Imaging
1.3.4 Drug Delivery
1.3.5 Radiotherapy
1.3.6 Immunotherapy
1.3.7 Phototherapy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nanotechnology in Cancer Treatment Market Perspective (2016-2027)
2.2 Nanotechnology in Cancer Treatment Growth Trends by Regions
2.2.1 Nanotechnology in Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nanotechnology in Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Nanotechnology in Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Nanotechnology in Cancer Treatment Industry Dynamic
2.3.1 Nanotechnology in Cancer Treatment Market Trends
2.3.2 Nanotechnology in Cancer Treatment Market Drivers
2.3.3 Nanotechnology in Cancer Treatment Market Challenges
2.3.4 Nanotechnology in Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanotechnology in Cancer Treatment Players by Revenue
3.1.1 Global Top Nanotechnology in Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Nanotechnology in Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Nanotechnology in Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nanotechnology in Cancer Treatment Revenue
3.4 Global Nanotechnology in Cancer Treatment Market Concentration Ratio
3.4.1 Global Nanotechnology in Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology in Cancer Treatment Revenue in 2020
3.5 Nanotechnology in Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Nanotechnology in Cancer Treatment Product Solution and Service
3.7 Date of Enter into Nanotechnology in Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanotechnology in Cancer Treatment Breakdown Data by Type
4.1 Global Nanotechnology in Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Nanotechnology in Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 Nanotechnology in Cancer Treatment Breakdown Data by Application
5.1 Global Nanotechnology in Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Nanotechnology in Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nanotechnology in Cancer Treatment Market Size (2016-2027)
6.2 North America Nanotechnology in Cancer Treatment Market Size by Type
6.2.1 North America Nanotechnology in Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Nanotechnology in Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Nanotechnology in Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Nanotechnology in Cancer Treatment Market Size by Application
6.3.1 North America Nanotechnology in Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Nanotechnology in Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Nanotechnology in Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Nanotechnology in Cancer Treatment Market Size by Country
6.4.1 North America Nanotechnology in Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Nanotechnology in Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Nanotechnology in Cancer Treatment Market Size (2016-2027)
7.2 Europe Nanotechnology in Cancer Treatment Market Size by Type
7.2.1 Europe Nanotechnology in Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Nanotechnology in Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Nanotechnology in Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Nanotechnology in Cancer Treatment Market Size by Application
7.3.1 Europe Nanotechnology in Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Nanotechnology in Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Nanotechnology in Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Nanotechnology in Cancer Treatment Market Size by Country
7.4.1 Europe Nanotechnology in Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Nanotechnology in Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology in Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nanotechnology in Cancer Treatment Market Size (2016-2027)
9.2 Latin America Nanotechnology in Cancer Treatment Market Size by Type
9.2.1 Latin America Nanotechnology in Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Nanotechnology in Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Nanotechnology in Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Nanotechnology in Cancer Treatment Market Size by Application
9.3.1 Latin America Nanotechnology in Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Nanotechnology in Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Nanotechnology in Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Nanotechnology in Cancer Treatment Market Size by Country
9.4.1 Latin America Nanotechnology in Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Nanotechnology in Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology in Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Nanotechnology in Cancer Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Combimatrix Corporation
11.2.1 Combimatrix Corporation Company Details
11.2.2 Combimatrix Corporation Business Overview
11.2.3 Combimatrix Corporation Nanotechnology in Cancer Treatment Introduction
11.2.4 Combimatrix Corporation Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.2.5 Combimatrix Corporation Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Nanotechnology in Cancer Treatment Introduction
11.3.4 GE Healthcare Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 Sigma-Tau Pharmaceuticals Inc.
11.4.1 Sigma-Tau Pharmaceuticals Inc. Company Details
11.4.2 Sigma-Tau Pharmaceuticals Inc. Business Overview
11.4.3 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Introduction
11.4.4 Sigma-Tau Pharmaceuticals Inc. Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.4.5 Sigma-Tau Pharmaceuticals Inc. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Nanotechnology in Cancer Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Mallinckrodt Plc
11.6.1 Mallinckrodt Plc Company Details
11.6.2 Mallinckrodt Plc Business Overview
11.6.3 Mallinckrodt Plc Nanotechnology in Cancer Treatment Introduction
11.6.4 Mallinckrodt Plc Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.6.5 Mallinckrodt Plc Recent Development
11.7 Merck & Company Inc.
11.7.1 Merck & Company Inc. Company Details
11.7.2 Merck & Company Inc. Business Overview
11.7.3 Merck & Company Inc. Nanotechnology in Cancer Treatment Introduction
11.7.4 Merck & Company Inc. Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.7.5 Merck & Company Inc. Recent Development
11.8 Nanosphere Inc.
11.8.1 Nanosphere Inc. Company Details
11.8.2 Nanosphere Inc. Business Overview
11.8.3 Nanosphere Inc. Nanotechnology in Cancer Treatment Introduction
11.8.4 Nanosphere Inc. Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.8.5 Nanosphere Inc. Recent Development
11.9 Pfizer, Inc.
11.9.1 Pfizer, Inc. Company Details
11.9.2 Pfizer, Inc. Business Overview
11.9.3 Pfizer, Inc. Nanotechnology in Cancer Treatment Introduction
11.9.4 Pfizer, Inc. Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.9.5 Pfizer, Inc. Recent Development
11.10 Celgene Corporation
11.10.1 Celgene Corporation Company Details
11.10.2 Celgene Corporation Business Overview
11.10.3 Celgene Corporation Nanotechnology in Cancer Treatment Introduction
11.10.4 Celgene Corporation Revenue in Nanotechnology in Cancer Treatment Business (2016-2021)
11.10.5 Celgene Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nanoparticles
Table 3. Key Players of Nanorods
Table 4. Key Players of Nanofibers
Table 5. Key Players of Graphene
Table 6. Key Players of Metal-Organic Frameworks
Table 7. Key Players of Nanobiosensors
Table 8. Key Players of Nanofluidic Devices
Table 9. Key Players of Nanotools
Table 10. Global Nanotechnology in Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Nanotechnology in Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Nanotechnology in Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Nanotechnology in Cancer Treatment Market Share by Regions (2016-2021)
Table 14. Global Nanotechnology in Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Nanotechnology in Cancer Treatment Market Share by Regions (2022-2027)
Table 16. Nanotechnology in Cancer Treatment Market Trends
Table 17. Nanotechnology in Cancer Treatment Market Drivers
Table 18. Nanotechnology in Cancer Treatment Market Challenges
Table 19. Nanotechnology in Cancer Treatment Market Restraints
Table 20. Global Nanotechnology in Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Nanotechnology in Cancer Treatment Market Share by Players (2016-2021)
Table 22. Global Top Nanotechnology in Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology in Cancer Treatment as of 2020)
Table 23. Ranking of Global Top Nanotechnology in Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Nanotechnology in Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Nanotechnology in Cancer Treatment Product Solution and Service
Table 27. Date of Enter into Nanotechnology in Cancer Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Nanotechnology in Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Nanotechnology in Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 31. Global Nanotechnology in Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Nanotechnology in Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Nanotechnology in Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Nanotechnology in Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 35. Global Nanotechnology in Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Nanotechnology in Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Nanotechnology in Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Nanotechnology in Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Nanotechnology in Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Nanotechnology in Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Nanotechnology in Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Nanotechnology in Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Nanotechnology in Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Nanotechnology in Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Nanotechnology in Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Nanotechnology in Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Nanotechnology in Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Nanotechnology in Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Nanotechnology in Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Nanotechnology in Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Nanotechnology in Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Nanotechnology in Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Nanotechnology in Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Nanotechnology in Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 67. Abbott Laboratories Company Details
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Nanotechnology in Cancer Treatment Product
Table 70. Abbott Laboratories Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 71. Abbott Laboratories Recent Development
Table 72. Combimatrix Corporation Company Details
Table 73. Combimatrix Corporation Business Overview
Table 74. Combimatrix Corporation Nanotechnology in Cancer Treatment Product
Table 75. Combimatrix Corporation Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 76. Combimatrix Corporation Recent Development
Table 77. GE Healthcare Company Details
Table 78. GE Healthcare Business Overview
Table 79. GE Healthcare Nanotechnology in Cancer Treatment Product
Table 80. GE Healthcare Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 81. GE Healthcare Recent Development
Table 82. Sigma-Tau Pharmaceuticals Inc. Company Details
Table 83. Sigma-Tau Pharmaceuticals Inc. Business Overview
Table 84. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Product
Table 85. Sigma-Tau Pharmaceuticals Inc. Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 86. Sigma-Tau Pharmaceuticals Inc. Recent Development
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Nanotechnology in Cancer Treatment Product
Table 90. Johnson & Johnson Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 91. Johnson & Johnson Recent Development
Table 92. Mallinckrodt Plc Company Details
Table 93. Mallinckrodt Plc Business Overview
Table 94. Mallinckrodt Plc Nanotechnology in Cancer Treatment Product
Table 95. Mallinckrodt Plc Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 96. Mallinckrodt Plc Recent Development
Table 97. Merck & Company Inc. Company Details
Table 98. Merck & Company Inc. Business Overview
Table 99. Merck & Company Inc. Nanotechnology in Cancer Treatment Product
Table 100. Merck & Company Inc. Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 101. Merck & Company Inc. Recent Development
Table 102. Nanosphere Inc. Company Details
Table 103. Nanosphere Inc. Business Overview
Table 104. Nanosphere Inc. Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 105. Nanosphere Inc. Recent Development
Table 106. Pfizer, Inc. Company Details
Table 107. Pfizer, Inc. Business Overview
Table 108. Pfizer, Inc. Nanotechnology in Cancer Treatment Product
Table 109. Pfizer, Inc. Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 110. Pfizer, Inc. Recent Development
Table 111. Celgene Corporation Company Details
Table 112. Celgene Corporation Business Overview
Table 113. Celgene Corporation Nanotechnology in Cancer Treatment Product
Table 114. Celgene Corporation Revenue in Nanotechnology in Cancer Treatment Business (2016-2021) & (US$ Million)
Table 115. Celgene Corporation Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanotechnology in Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Nanoparticles Features
Figure 3. Nanorods Features
Figure 4. Nanofibers Features
Figure 5. Graphene Features
Figure 6. Metal-Organic Frameworks Features
Figure 7. Nanobiosensors Features
Figure 8. Nanofluidic Devices Features
Figure 9. Nanotools Features
Figure 10. Global Nanotechnology in Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 11. Cancer Detection Case Studies
Figure 12. Imaging Case Studies
Figure 13. Drug Delivery Case Studies
Figure 14. Radiotherapy Case Studies
Figure 15. Immunotherapy Case Studies
Figure 16. Phototherapy Case Studies
Figure 17. Nanotechnology in Cancer Treatment Report Years Considered
Figure 18. Global Nanotechnology in Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Nanotechnology in Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Nanotechnology in Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 21. Global Nanotechnology in Cancer Treatment Market Share by Regions (2022-2027)
Figure 22. Global Nanotechnology in Cancer Treatment Market Share by Players in 2020
Figure 23. Global Top Nanotechnology in Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology in Cancer Treatment as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Nanotechnology in Cancer Treatment Revenue in 2020
Figure 25. Global Nanotechnology in Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 26. Global Nanotechnology in Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 27. North America Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Nanotechnology in Cancer Treatment Market Share by Type (2016-2027)
Figure 29. North America Nanotechnology in Cancer Treatment Market Share by Application (2016-2027)
Figure 30. North America Nanotechnology in Cancer Treatment Market Share by Country (2016-2027)
Figure 31. United States Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Nanotechnology in Cancer Treatment Market Share by Type (2016-2027)
Figure 35. Europe Nanotechnology in Cancer Treatment Market Share by Application (2016-2027)
Figure 36. Europe Nanotechnology in Cancer Treatment Market Share by Country (2016-2027)
Figure 37. Germany Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Nanotechnology in Cancer Treatment Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Nanotechnology in Cancer Treatment Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Nanotechnology in Cancer Treatment Market Share by Region (2016-2027)
Figure 47. China Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Nanotechnology in Cancer Treatment Market Share by Type (2016-2027)
Figure 55. Latin America Nanotechnology in Cancer Treatment Market Share by Application (2016-2027)
Figure 56. Latin America Nanotechnology in Cancer Treatment Market Share by Country (2016-2027)
Figure 57. Mexico Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Nanotechnology in Cancer Treatment Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Nanotechnology in Cancer Treatment Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Nanotechnology in Cancer Treatment Market Share by Country (2016-2027)
Figure 63. Turkey Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Nanotechnology in Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Abbott Laboratories Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 67. Combimatrix Corporation Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 68. GE Healthcare Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 69. Sigma-Tau Pharmaceuticals Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 70. Johnson & Johnson Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 71. Mallinckrodt Plc Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 72. Merck & Company Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 73. Nanosphere Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 74. Pfizer, Inc. Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 75. Celgene Corporation Revenue Growth Rate in Nanotechnology in Cancer Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界のドラッグデリバリーにおけるナノテクノロジー市場規模・現状・予測（2021年-2027年） Drug Delivery Systems (DDS) refers to the different Delivery forms of various therapeutic drugs adopted by people in the process of disease prevention and treatment, which were called dosage forms in pharmacy before the 1960s. Rising demand from Asia-Pacific region a major driver for the growth of t…- 世界のドラッグデリバリーにおけるナノテクノロジー市場規模・現状・予測（2021年-2027年） Drug Delivery Systems (DDS) refers to the different Delivery forms of various therapeutic drugs adopted by people in the process of disease prevention and treatment, which were called dosage forms in pharmacy before the 1960s. Rising demand from Asia-Pacific region a major driver for the growth of t…
- 世界のナノテクノロジードラッグデリバリー市場規模・現状・予測（2021年-2027年） Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e.…
- 世界の下咽頭がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypopharyngeal Cancer Treatment Market The global Hypopharyngeal Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
- 世界の陰茎がん治療市場規模・現状・予測（2021年-2027年） Therapy of penile cancer. Market Analysis and Insights: Global Penile Cancer Treatment Market The global Penile Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…